EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploring extracellular RNA as drivers of chemotherapy resistance in cancer

Yumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, Rabab Fatima, Mudasir Maqbool, Sumel Ashique, Najeeb Ullah Khan, Ajay Singh Bisht, Gaurav Gupta

Molecular Biology Reports · 2025

DOI: 10.1007/s11033-025-10263-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Yumna Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology and Genetic Engineering, The University of Agriculture Peshawar, Peshawar, PO Box 25130, Pakistan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 153 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy resistance (CR) represents one of the most important barriers to effective oncological therapy and often leads to ineffective intervention and unfavorable clinical prognosis. Emerging studies have emphasized the vital significance of extracellular RNA (exRNA) in influencing CR. This thorough assessment intends to explore the multifaceted contributions of exRNA, such as exosomal RNA, microRNAs, long non-coding RNAs, and circular RNAs, to CR in cancer. We discuss the mechanisms by which exRNA facilitates drug resistance, such as modulating gene expression, influencing the tumor microenvironment, and facilitating intercellular communication. Furthermore, we examine the potential of exRNA as prognostic factor for determining oncology treatment efficacy and their emerging role as therapeutic targets. Diagnostic and prognostic applications of exRNA biomarkers are considered, alongside current methodologies for their detection and quantification. Additionally, we review recent advances in exRNA-targeted therapies, highlighting ongoing clinical trials and therapeutic strategies aimed at overcoming chemoresistance. Despite the promise of exRNA research, several challenges remain, including technical limitations and the biological complexity of exRNA networks. This review underscores the importance of continued investigation into exRNA biology and its therapeutic potential, which in the future may provide new avenues for cancer treatment and tailored medical strategies. By elucidating the role of exRNA in CR, this article aims to provide a comprehensive resource for researchers and clinicians seeking to improve the effectiveness of carcinoma management approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmNeoplasmsHumansTumor MicroenvironmentBiomarkers, TumorMicroRNAsGene Expression Regulation, NeoplasticRNA, CircularRNA, Long NoncodingExosomesPrognosis

Stichwörter der Autor:innen

BiomarkersDrug resistanceExRNA-targeted therapyExosomal RNAsTumor microenvironment

Substanzen

Biomarkers, TumorMicroRNAsRNA, CircularRNA, Long Noncoding

Autor:innen und Institutionen

  • Institute of Biotechnology and Genetic Engineering, The University of Agriculture Peshawar, Peshawar, PO Box 25130, Pakistan.
  • Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, 248007, India. sadiquehussain007@gmail.com.
  • Protein Engineering Lab, School of Biosciences and Technology, Vellore Institute of Technology, Katpadi, Vellore, Tamil Nadu, 632014, India.
  • Department of Chemistry, Energy Acres, University of Petroleum & Energy Studies, Dehradun, Uttarakhand, 248007, India.
  • Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Jammu, Srinagar, Kashmir, 190006, India.
  • School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India.

Zitieren

APA

Khan, Y., Hussain, M. S., Ramalingam, P. S., Fatima, R., Maqbool, M., Ashique, S., Khan, N. U., Bisht, A. S., & Gupta, G. (2025). Exploring extracellular RNA as drivers of chemotherapy resistance in cancer. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10263-2

Vancouver

Khan Y, Hussain MS, Ramalingam PS, Fatima R, Maqbool M, Ashique S, et al. Exploring extracellular RNA as drivers of chemotherapy resistance in cancer. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10263-2

BibTeX
@article{Khan2025,
  author = {Khan, Yumna and Hussain, Md Sadique and Ramalingam, Prasanna Srinivasan and Fatima, Rabab and Maqbool, Mudasir and Ashique, Sumel and Khan, Najeeb Ullah and Bisht, Ajay Singh and Gupta, Gaurav},
  title = {Exploring extracellular RNA as drivers of chemotherapy resistance in cancer},
  journal = {Molecular Biology Reports},
  year = {2025},
  doi = {10.1007/s11033-025-10263-2}
}
Kostenlos starten →